{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:49:17Z","timestamp":1783360157726,"version":"3.54.6"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,3,2]]},"DOI":"10.18632\/oncotarget.24417","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T10:16:06Z","timestamp":1517912166000},"page":"13501-13516","source":"Crossref","is-referenced-by-count":14,"title":["Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer"],"prefix":"10.18632","volume":"9","author":[{"given":"Celia","family":"Pinto-D\u00edez","sequence":"first","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Garc\u00eda-Recio","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Isabel","family":"P\u00e9rez-Morgado","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Sanz-Criado","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sacrist\u00e1n","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Val","family":"Toledo-Lobo","sequence":"additional","affiliation":[{"name":"Departamento de Biomedicina y Biotecnolog\u00eda, Universidad de Alcal\u00e1, Alcal\u00e1 de Henares, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"P\u00e9rez-Mies","sequence":"additional","affiliation":[{"name":"Servicio de Anatom\u00eda Patol\u00f3gica, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Esteban-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Sevicio de Anatom\u00eda Patol\u00f3gica, IDYPAZ-Hospital La Paz, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Pascual","sequence":"additional","affiliation":[{"name":"Servicio de Anatom\u00eda Patol\u00f3gica, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Garcia-Villanueva","sequence":"additional","affiliation":[{"name":"Servicio de Anatom\u00eda Patol\u00f3gica, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Mart\u00ednez-Ja\u00f1ez","sequence":"additional","affiliation":[{"name":"Servicio de Oncolog\u00eda, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor M.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elena","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Servicio de Bioqu\u00edmica-Investigaci\u00f3n, IRYCIS-Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.4161\/cc.6.19.4914","article-title":"Breast tumor heterogeneity: cancer stem cells or clonal evolution?","volume":"6","author":"Polyak","year":"2007","journal-title":"Cell Cycle"},{"key":"2","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"Perou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/emboj\/16.8.1921","article-title":"MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates","volume":"16","author":"Hunter","year":"1997","journal-title":"EMBO J"},{"key":"4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yexcr.2004.06.006","article-title":"Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1","volume":"299","author":"Martin","year":"2004","journal-title":"Exp Cell Res"},{"key":"5","doi-asserted-by":"publisher","first-page":"44197","DOI":"10.1074\/jbc.M302398200M302398200","article-title":"Features in the N and C termini of the MAPK-interacting kinase Mnk1 mediate its nucleocytoplasmic shuttling","volume":"278","author":"Proud","year":"2003","journal-title":"J Biol Chem"},{"key":"6","doi-asserted-by":"crossref","first-page":"17887","DOI":"10.1074\/jbc.272.28.17887","article-title":"Involvement of stress-activated protein kinase and p38\/RK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells","volume":"272","author":"McKendrick","year":"1997","journal-title":"J Biol Chem"},{"key":"7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2007.08.022","article-title":"Translational control: a target for cancer therapy","volume":"258","author":"Kratzke","year":"2007","journal-title":"Cancer Lett"},{"key":"8","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1038\/sj.onc.1207545","article-title":"eIF-4E expression and its role in malignancies and metastases","volume":"23","author":"Graff","year":"2004","journal-title":"Oncogene"},{"key":"9","doi-asserted-by":"publisher","first-page":"981679","DOI":"10.1155\/2009\/981679","article-title":"Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer","volume":"2009","author":"Borden","year":"2009","journal-title":"J Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4161\/cbt.8.15.8960","article-title":"Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues","volume":"8","author":"Sun","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"11","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1038\/onc.2012.306","article-title":"Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2\/eIF4E pathway","volume":"32","author":"Sette","year":"2013","journal-title":"Oncogene"},{"key":"12","doi-asserted-by":"publisher","first-page":"8639","DOI":"10.1158\/0008-5472.CAN-04-2677","article-title":"Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities","volume":"64","author":"Borden","year":"2004","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1074\/jbc.M607368200","article-title":"MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines","volume":"282","author":"Sturgill","year":"2007","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1038\/mtna.2015.50","article-title":"Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells","volume":"5","author":"Gonzalez","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"key":"15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.18632\/oncotarget.1528","article-title":"First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines","volume":"5","author":"Njar","year":"2014","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/sj.onc.1210785","article-title":"MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA","volume":"27","author":"Blaydes","year":"2008","journal-title":"Oncogene"},{"key":"17","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1101\/gad.1604407","article-title":"Dissecting eIF4E action in tumorigenesis","volume":"21","author":"Lowe","year":"2007","journal-title":"Genes Dev"},{"key":"18","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1128\/MCB.24.15.6539-6549.200424\/15\/6539","article-title":"Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development","volume":"24","author":"Fukunaga","year":"2004","journal-title":"Mol Cell Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.4161\/cbt.10.7.12965","article-title":"The role of MNK proteins and eIF4E phosphorylation in breast cancer cell proliferation and survival","volume":"10","author":"Blaydes","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"20","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1038\/onc.2011.617","article-title":"MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition","volume":"31","author":"Dunn","year":"2012","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1038\/sj.onc.1210431","article-title":"Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies","volume":"26","author":"Stokoe","year":"2007","journal-title":"Oncogene"},{"key":"22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1593\/neo.10704","article-title":"Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E","volume":"12","author":"Sun","year":"2010","journal-title":"Neoplasia"},{"key":"23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc2824","article-title":"Translational control in cancer","volume":"10","author":"Schneider","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"24","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/bcr3343","article-title":"Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer","volume":"14","author":"Gonzalez-Angulo","year":"2012","journal-title":"Breast Cancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10549-013-2671-2","article-title":"Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment","volume":"141","author":"Nevanlinna","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12094-014-1203-9","article-title":"The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets","volume":"16","author":"Peg","year":"2014","journal-title":"Clin Transl Oncol"},{"key":"27","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/0008-5472.CAN-10-3112","article-title":"MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-beta signaling pathway in human glioblastoma","volume":"71","author":"Hemmings","year":"2011","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s12094-017-1646-x","article-title":"Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer","volume":"19","author":"Liu","year":"2017","journal-title":"Clin Transl Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1158\/0008-5472.CAN-06-1788","article-title":"Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer","volume":"67","author":"Hung","year":"2007","journal-title":"Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2407-14-124","article-title":"Wnt modulates MCL1 to control cell survival in triple negative breast cancer","volume":"14","author":"Ann","year":"2014","journal-title":"BMC Cancer"},{"key":"31","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1038\/cdd.2015.73","article-title":"Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer","volume":"22","author":"Fesik","year":"2015","journal-title":"Cell Death Differ"},{"key":"32","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/nm.4198","article-title":"PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer","volume":"22","author":"Cheang","year":"2016","journal-title":"Nat Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-16-2622","article-title":"Targeted degradation of BET proteins in triple-negative breast cancer","volume":"77","author":"Xu","year":"2017","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1158\/1535-7163.MCT-14-0928","article-title":"MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor","volume":"14","author":"Phillips","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1369\/jhc.2009.952929","article-title":"Eukaryotic Initiation Factors (eIF) 2 alpha and 4E Expression, Localization, and Phosphorylation in Brain Tumors","volume":"57","author":"Elena Martin","year":"2009","journal-title":"Journal of Histochemistry & Cytochemistry"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:51:48Z","timestamp":1589035908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":35,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,3,2]]}},"alternative-id":["24417","29568373"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24417","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]}}}